Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 23 Neoplasm Metastasis 4 Endometrial Neoplasms 3 Triple Negative Breast Neoplasms 2 Recurrence 2 Polycystic Ovary Syndrome 2 Infertility 2 Carcinoma, Intraductal, Noninfiltrating 2 Breast Neoplasms, Male 2 Uterine Cervical Neoplasms 1 Unilateral Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sexual Dysfunctions, Psychological 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms by Site 1 Neoplasms 1 Leiomyoma 1 Hereditary Sensory and Autonomic Neuropathies 1 Head and Neck Neoplasms 1 HR+/HER2- Breast Cancer 1 HER2 Negative Breast Cancer 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Ductal 1 Breast Neoplasm Female 1 Breast Diseases 1 Breast Carcinoma In Situ 1 Anovulation 1 Anatomic Stage II Breast Cancer AJCC v8 1 Advanced HR+/HER2- Breast Cancer 1

Interventions

Tamoxifen 1 Letrozole 1 Clomiphene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Anovulation × Letrozole × 30 days × Clear all

NCT07616973 2026-06-01

LET-CC-TAM

Sana'a University

Phase 3 Active not recruiting

Anovulation, Infertility, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡